Are Concessions In FDA's Lab-Developed Tests Rule Enough?

By Dominick DiSabatino and Audrey Mercer · May 8, 2024, 6:56 PM EDT

On April 29, the U.S. Food and Drug Administration issued a highly anticipated — and highly controversial — final rule that rolls out a four-year, five-stage plan that will phase out...

To view the full article, register now.